CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the stocks that could 10x over the next 10 years. Piper Sandler boosted its ...

CRISPR Cas9 gene therapy explained with DNA scissors, hereditary diseases treatment, and designer babies ethical dilemmas ...

Any molecular biologist will tell you that genetic engineering is tricky. But up until recently we might be witnessing a new ...

Scientists at Rothamsted Research have successfully developed wheat with dramatically reduced levels of asparagine, without ...

A US patent board last week backed the Broad Institute’s claim to CRISPR use in human and animal cells, not the Nobel winners ...

Samarth Kulkarni is one of the most consequential figures in modern biotechnology, widely recognised for his role in transforming CRISPR Therapeutics from an early-stage gene-editing company into the ...

Gene drives—a genetic engineering approach that quickly spreads specific genetic changes throughout a population, whether to ...

Trace the timeline of CRISPR-Cas9 from its 2012 discovery to the latest AI-driven advancements and "N-of-1" clinical ...

Detailed price information for Editas Medicine (EDIT-Q) from The Globe and Mail including charting and trades.

Most people who have heard of clustered regularly interspaced short palindromic repeats (more commonly known as CRISPR) associate it with gene editing—the precise molecular scissors that allow ...

Scientists from the University of Sheffield, the MRC Laboratory of Medical Sciences (LMS) and Imperial College London have helped solve a decade-long ...

A mystery surrounding why powerful gene-editing technology that has driven major advances in medicine over the past decade can sometimes make mistakes, has been solved with the help of scientists from ...